Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 2/20 | 0.32 |
| ▸ | RXRB | P28702 | 2/20 | 0.32 |
| ▸ | RXRG | P48443 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LDHA | P00338 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 5/20 | 0.31 |
| ▸ | PPARA | Q07869 | 5/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 4/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7149958 | 0.85 | GABRA1 (0.41) | MEN1KMT2A | |
| SCHEMBL29362810 | 0.85 | GABRA1 (0.41) | MEN1KMT2A | |
| SCHEMBL16245811 | 0.81 | — | — | |
| SCHEMBL16245756 | 0.78 | GRIN2D (0.33) | — | |
| SCHEMBL16245763 | 0.77 | TRPA1 (0.34) | RXRARXRBRXRGALDH1A1PPARG | |
| SCHEMBL17748405 | 0.77 | GABRA1 (0.39) | MEN1KMT2A | |
| SCHEMBL31680062 | 0.77 | GABRA1 (0.39) | MEN1KMT2A | |
| SCHEMBL16245721 | 0.75 | GRIN2D (0.43) | — | |
| SCHEMBL16245723 | 0.73 | GRIN2D (0.41) | — | |
| SCHEMBL23248044 | 0.73 | ESR1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250143297-A1 | Arthropod Control Compositions | FIRMENICH SA (CH) | 2025-05-08 | — | — | US | claimed |
| EP-4447678-A1 | ARTHROPOD CONTROL COMPOSITIONS | Firmenich SA (CH) | 2024-10-23 | — | — | EP | claimed |
| WO-2024084006-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2024-04-25 | — | — | WO | claimed |
| WO-2023139051-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2023-07-27 | — | — | WO | claimed |
| US-20250143297-A1 | Arthropod Control Compositions | FIRMENICH SA (CH) | 2025-05-08 | — | — | US | disclosed |
| EP-4447678-A1 | ARTHROPOD CONTROL COMPOSITIONS | Firmenich SA (CH) | 2024-10-23 | — | — | EP | disclosed |
| WO-2023139051-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2023-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250143297-A1 | Arthropod Control Compositions | AGO2, EXOSC9, C5 | RXRA 4450/4885RXRB 4528/4885RXRG 4623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.